GO:0071142 homomeric SMAD protein complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071142 describes a homomeric SMAD protein complex composed of a single type of SMAD family protein, such as a homotrimer of SMAD1, SMAD2, or SMAD3.
• In the absence of SMAD4, phosphorylation of R-SMADs leads to their homotrimerization, but these complexes do not appear to import into the nucleus and are assumed to be transcriptionally inactive.
• Homomeric SMAD complexes are distinct from heteromeric SMAD complexes that contain SMAD4 and regulate canonical TGF-beta/BMP target genes.
• BMP receptor oligomerization states influence whether homomeric or heteromeric SMAD complexes form and which signaling pathway is activated.
• The formation and stability of homomeric SMAD complexes can be regulated by accessory proteins such as UBE2O and TbetaRIII.
• Studying homomeric SMAD complexes requires tools such as knockout, knock-in, and overexpression cell models combined with biochemical and imaging methods.
Description
The homomeric SMAD protein complex (GO:0071142) is a cellular component defined as a protein complex composed of a single type of SMAD family protein. SMAD proteins are intracellular transducers of transforming growth factor beta (TGF-beta) and bone morphogenetic protein (BMP) signaling, and they assemble into distinct complexes that determine transcriptional outcomes. In the absence of SMAD4, phosphorylated receptor-regulated SMADs (R-SMADs) can form homotrimers, but these complexes are not thought to enter the nucleus and are considered transcriptionally inactive. This makes the homomeric SMAD complex an important node for understanding how cells interpret TGF-beta/BMP signals and how signaling specificity is achieved. Homomeric SMAD complexes are relevant to researchers because they represent a non-canonical or alternative state of SMAD assembly that may act as a regulatory sink or modulate signaling intensity. The balance between homomeric and heteromeric SMAD complexes can influence downstream gene expression, and perturbations in this balance have been linked to diseases such as cancer. For example, loss of SMAD4 function in pancreatic tumors can alter SMAD complex composition and stability, highlighting the importance of understanding homomeric SMAD complexes in disease contexts. Recent studies have begun to uncover how receptor oligomerization and accessory proteins control the formation of homomeric versus heteromeric SMAD complexes. This article provides a research-grade overview of GO:0071142, covering its definition, structure, molecular mechanisms, key genes, disease relevance, and experimental methods for studying it.
homomeric SMAD protein complex At A Glance
| GO ID | GO:0071142 |
|---|---|
| GO term | homomeric SMAD protein complex |
| Ontology | cellular_component |
| Synonym | SMAD1 homotrimer complex, SMAD1 protein complex, SMAD2 homotrimer complex, SMAD2 protein complex, SMAD3 homotrimer complex, SMAD3 protein complex |
| Major function | Composed of a single type of SMAD family protein; formed by phosphorylation-induced homotrimerization of R-SMADs in the absence of SMAD4; assumed to be transcriptionally inactive and not imported into the nucleus |
| Related signaling pathways | TGF-beta and BMP signaling |
| Key SMAD proteins | SMAD1, SMAD2, SMAD3 |
| Subcellular localization | Cytoplasmic; not imported into the nucleus |
| Regulatory modifiers | UBE2O, TbetaRIII |
What Is GO:0071142?
GO:0071142, homomeric SMAD protein complex, is a cellular component defined as a protein complex composed of a single type of SMAD family protein. In the absence of SMAD4, phosphorylation of R-SMADs results in their homotrimerization; however, these complexes do not appear to import into the nucleus and are assumed to be transcriptionally inactive. Synonyms include SMAD1 homotrimer complex, SMAD1 protein complex, SMAD2 homotrimer complex, SMAD2 protein complex, SMAD3 homotrimer complex, and SMAD3 protein complex.
Why Is homomeric SMAD protein complex Important in Cell Biology?
The homomeric SMAD protein complex is important because it represents a distinct assembly state of SMAD proteins that can modulate TGF-beta and BMP signaling outcomes. Understanding how homomeric complexes form and are regulated provides insight into the mechanisms that control cell proliferation, differentiation, and apoptosis, and how these processes go awry in diseases such as cancer.
• Provides a mechanism for regulating the availability of R-SMADs for heteromeric complex formation with SMAD4.
• Influences the specificity of TGF-beta versus BMP signaling through receptor oligomerization states.
• May act as a cytoplasmic reservoir of inactive SMADs, preventing inappropriate nuclear signaling.
• Its dysregulation is implicated in cancer, including pancreatic tumors with SMAD4 loss.
• Serves as a potential target for modulating TGF-beta signaling in fibrosis and cancer.
• Can be studied using CRISPR knockout and knock-in models to dissect SMAD complex assembly.
• Its formation is affected by accessory proteins such as UBE2O and TbetaRIII.
• Understanding homomeric SMAD complexes aids in interpreting gene expression changes in TGF-beta/BMP-related diseases.
• Provides a basis for developing therapeutics that target SMAD complex formation.
• Helps explain why some SMAD-mediated responses are independent of SMAD4.
What Happens During homomeric SMAD protein complex?
Phosphorylation of R-SMADs
In simple terms: Receptor kinases add phosphate groups to SMAD proteins, which is the first step toward complex formation.
In the absence of SMAD4, phosphorylation of R-SMADs by activated type I TGF-beta or BMP receptors triggers a conformational change that promotes homotrimerization. This phosphorylation is a key regulatory step that determines whether R-SMADs assemble into homomeric or heteromeric complexes.
Homotrimerization
In simple terms: Three identical SMAD proteins stick together to form a trimer.
Phosphorylated R-SMADs can self-associate to form homotrimers, which are the core of the homomeric SMAD protein complex. These homotrimers are distinct from heteromeric complexes that contain SMAD4 and are thought to be transcriptionally inactive.
Lack of nuclear import
In simple terms: These homomeric complexes stay outside the nucleus.
Unlike heteromeric SMAD complexes, homomeric SMAD complexes do not appear to import into the nucleus, which prevents them from directly regulating transcription. This spatial restriction is a key feature that distinguishes them from active SMAD complexes.
Regulation by receptor oligomerization
In simple terms: How receptors pair up determines which type of SMAD complex forms.
The mode of BMP receptor oligomerization determines whether homomeric or heteromeric SMAD complexes are formed, thereby influencing downstream signaling pathways. Stable homomeric receptor complexes can favor the formation of homomeric SMAD complexes.
Modulation by accessory proteins
In simple terms: Other proteins can stabilize or degrade these SMAD complexes.
Accessory proteins such as UBE2O can target orphan SMAD proteins for degradation, thereby affecting the availability of SMADs for homomeric complex formation. TbetaRIII can independently bind type I and type II TGF-beta receptors to inhibit TGF-beta signaling, potentially altering SMAD complex assembly.
Key Genes Involved in GO:0071142 homomeric SMAD protein complex
The following genes and proteins are central to the formation, regulation, and function of the homomeric SMAD protein complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SMAD1 | R-SMAD that can form homotrimers in the absence of SMAD4 | BMP signaling; homomeric complex formation |
| SMAD2 | R-SMAD that can form homotrimers in the absence of SMAD4 | TGF-beta signaling; homomeric complex formation |
| SMAD3 | R-SMAD that can form homotrimers in the absence of SMAD4 | TGF-beta signaling; homomeric complex formation |
| SMAD4 | Co-SMAD that forms heteromeric complexes with R-SMADs; its absence favors homomeric complexes | TGF-beta signaling; cancer |
| TGFBR1 | Type I TGF-beta receptor that phosphorylates R-SMADs | TGF-beta signaling; receptor oligomerization |
| TGFBR2 | Type II TGF-beta receptor that activates type I receptor | TGF-beta signaling; receptor oligomerization |
| BMPR1 | Type I BMP receptor that phosphorylates SMAD1/5/8 | BMP signaling; homomeric complex formation |
| BMPR2 | Type II BMP receptor that activates type I receptor | BMP signaling; receptor oligomerization |
| UBE2O | Atypical ubiquitin ligase that targets orphan SMAD proteins for degradation | Regulation of SMAD stability |
| TGFBR3 | TbetaRIII, which binds TGF-beta receptors and inhibits signaling | Modulation of TGF-beta signaling |
| COL7A1 | Target gene activated by SMAD3/4-dependent TGF-beta signaling | TGF-beta transcriptional output |
| SMAD5 | R-SMAD in BMP signaling that can potentially form homomeric complexes | BMP signaling |
| SMAD8 | R-SMAD in BMP signaling that can potentially form homomeric complexes | BMP signaling |
| SMAD6 | Inhibitory SMAD that can interfere with R-SMAD phosphorylation | Negative regulation of SMAD signaling |
| SMAD7 | Inhibitory SMAD that can interfere with R-SMAD phosphorylation | Negative regulation of SMAD signaling |
| SMURF1 | E3 ubiquitin ligase that targets SMADs for degradation | Regulation of SMAD stability |
| SMURF2 | E3 ubiquitin ligase that targets SMADs for degradation | Regulation of SMAD stability |
| NEDD4L | E3 ubiquitin ligase that can regulate SMAD stability | Regulation of SMAD stability |
How Is homomeric SMAD protein complex Regulated?
The formation and stability of homomeric SMAD protein complexes are regulated at multiple levels. Phosphorylation of R-SMADs by type I receptors is a prerequisite for homotrimerization, and the absence of SMAD4 favors this assembly state. Receptor oligomerization modes, such as those of BMP receptors, determine whether homomeric or heteromeric SMAD complexes are formed. Accessory proteins such as UBE2O can target orphan SMAD proteins for degradation, thereby limiting the pool available for homomeric complex formation. Additionally, inhibitory SMADs (SMAD6 and SMAD7) and E3 ubiquitin ligases (SMURF1, SMURF2, NEDD4L) can negatively regulate SMAD stability and activity. TbetaRIII can bind TGF-beta receptors and inhibit signaling, potentially affecting SMAD complex assembly.
homomeric SMAD protein complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SMAD4 | Pancreatic cancer; loss of function leads to decreased stability | Knockout of SMAD4 in pancreatic cancer cell lines |
| SMAD3 | TGF-beta signaling in fibrosis and cancer | Point mutation of SMAD3 phosphorylation sites |
| SMAD2 | TGF-beta signaling in cancer | Knockout of SMAD2 in cancer cell lines |
| TGFBR3 | Modulation of TGF-beta signaling in cancer | Overexpression of TGFBR3 in cancer cells |
| UBE2O | Regulation of SMAD stability in cancer | Knockout of UBE2O in cancer cell lines |
Cancer
Dysregulation of SMAD complex formation is implicated in cancer. Loss of SMAD4 function in pancreatic tumors, often through C-terminal truncation, leads to decreased SMAD4 stability and altered SMAD complex composition, which may shift the balance toward homomeric SMAD complexes. This can contribute to uncontrolled cell proliferation and tumor progression.
Fibrosis
TGF-beta signaling, in which SMAD complexes play a central role, is a key driver of fibrosis. Homomeric SMAD complexes may modulate the intensity or duration of TGF-beta signaling, thereby influencing fibrotic responses. Targeting SMAD complex assembly could be a therapeutic strategy for fibrotic diseases.
Developmental disorders
Proper SMAD complex formation is essential for embryonic development. Nuclear accumulation of SMAD complexes occurs only after the midblastula transition in Xenopus, indicating that temporal control of SMAD complex localization is critical for development. Disruption of homomeric versus heteromeric SMAD complex balance could lead to developmental abnormalities.
From homomeric SMAD protein complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of SMAD4 increase homomeric SMAD complex formation? | SMAD4 knockout cell line |
| Do point mutations in R-SMAD phosphorylation sites prevent homotrimerization? | Point mutation knock-in of SMAD2/3 phosphorylation sites |
| Can tagged SMAD proteins be used to visualize homomeric complexes? | Knock-in of fluorescent or epitope tags on SMAD1/2/3 |
| Does overexpression of SMAD3 drive homomeric complex formation? | Overexpression of SMAD3 in cell lines |
| Does UBE2O regulate homomeric SMAD complex stability? | UBE2O knockout or overexpression |
| Does TbetaRIII inhibit homomeric SMAD complex formation? | TbetaRIII overexpression or knockout |
How to Study the homomeric SMAD protein complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between SMAD proteins | Detecting homomeric complexes |
| Western blotting | Protein expression and phosphorylation status | Assessing SMAD activation |
| Fluorescence microscopy | Subcellular localization of SMAD proteins | Distinguishing nuclear vs cytoplasmic complexes |
| Luciferase reporter assay | Transcriptional activity of SMAD complexes | Measuring SMAD-dependent gene expression |
| CRISPR knockout screening | Genes required for homomeric complex formation | Identifying novel regulators |
| Proteomics | Protein composition of SMAD complexes | Characterizing complex components |
| RNA-seq | Global gene expression changes | Downstream effects of SMAD complex modulation |
| Chromatin immunoprecipitation | DNA binding by SMAD complexes | Identifying direct target genes |
Biochemical fractionation and co-immunoprecipitation
Co-immunoprecipitation followed by western blotting can detect homomeric SMAD complexes in cell lysates. Using antibodies specific to SMAD1, SMAD2, or SMAD3, researchers can assess complex formation under different signaling conditions.
Fluorescence microscopy
Fluorescently tagged SMAD proteins can be expressed in cells to visualize their subcellular localization. Homomeric SMAD complexes are expected to remain cytoplasmic, whereas heteromeric complexes accumulate in the nucleus.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes that regulate homomeric SMAD complex formation or function. This approach can uncover novel modifiers of TGF-beta/BMP signaling.
Transcriptional reporter assays
SMAD-responsive luciferase reporters can measure transcriptional activity. Homomeric SMAD complexes are assumed to be transcriptionally inactive, so their presence may correlate with reduced reporter activity.
How CRISPR Can Be Used to Study GO:0071142 homomeric SMAD protein complex
Knockout
CRISPR knockout of SMAD4 can be used to force the formation of homomeric SMAD complexes, as the absence of SMAD4 prevents heteromeric complex assembly. Knocking out SMAD1, SMAD2, or SMAD3 can abolish specific homomeric complexes and reveal their contributions to signaling.
Point Mutation
Point mutations in the phosphorylation sites of R-SMADs can prevent their activation and subsequent homotrimerization. CRISPR-mediated knock-in of such mutations allows precise dissection of phosphorylation-dependent homomeric complex formation.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous SMAD loci enables visualization and purification of homomeric SMAD complexes under native expression conditions. This approach avoids artifacts from overexpression.
Overexpression
Overexpression of SMAD proteins can drive the formation of homomeric complexes and amplify signaling outputs. This is useful for studying the biochemical properties of these complexes and their downstream effects.
How EDITGENE Supports homomeric SMAD protein complex Research
Researchers studying homomeric SMAD protein complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for homomeric SMAD protein complex research.
Frequently Asked Questions About homomeric SMAD protein complex
What is a homomeric SMAD protein complex?
A homomeric SMAD protein complex is a protein complex composed of a single type of SMAD family protein, such as a homotrimer of SMAD1, SMAD2, or SMAD3. It forms when R-SMADs are phosphorylated in the absence of SMAD4 and is thought to be transcriptionally inactive.
What genes are involved in homomeric SMAD protein complex?
The main genes are SMAD1, SMAD2, and SMAD3, which encode the R-SMADs that can form homotrimers. Other related genes include SMAD4, TGFBR1, TGFBR2, BMPR1, BMPR2, UBE2O, and TGFBR3.
Where is the homomeric SMAD protein complex located?
It is located in the cytoplasm and does not appear to import into the nucleus, unlike heteromeric SMAD complexes.
What is the function of the homomeric SMAD protein complex?
It is assumed to be transcriptionally inactive and may serve as a cytoplasmic reservoir of SMAD proteins, regulating the availability of R-SMADs for heteromeric complex formation with SMAD4.
How is the homomeric SMAD protein complex formed?
It forms when R-SMADs are phosphorylated by activated type I TGF-beta or BMP receptors, leading to their homotrimerization in the absence of SMAD4.
What is the difference between homomeric and heteromeric SMAD complexes?
Homomeric SMAD complexes consist of a single type of SMAD protein and are transcriptionally inactive, while heteromeric complexes contain SMAD4 and R-SMADs, import into the nucleus, and regulate transcription.
Which diseases are associated with homomeric SMAD protein complex?
Dysregulation of SMAD complex formation is implicated in cancer, particularly pancreatic cancer with SMAD4 loss, and in fibrosis and developmental disorders.
How can I study homomeric SMAD protein complexes?
You can use co-immunoprecipitation, fluorescence microscopy, CRISPR knockout/knock-in models, and transcriptional reporter assays to study these complexes.
What are the synonyms for homomeric SMAD protein complex?
Synonyms include SMAD1 homotrimer complex, SMAD1 protein complex, SMAD2 homotrimer complex, SMAD2 protein complex, SMAD3 homotrimer complex, and SMAD3 protein complex.
Why is the homomeric SMAD protein complex important in TGF-beta signaling?
It provides a mechanism to regulate the pool of active R-SMADs and may modulate the intensity and specificity of TGF-beta and BMP signaling.
Conclusion
The homomeric SMAD protein complex (GO:0071142) is a distinct assembly state of SMAD proteins that forms in the absence of SMAD4 and is thought to be transcriptionally inactive. Its formation is regulated by receptor phosphorylation, oligomerization states, and accessory proteins, and it plays a role in modulating TGF-beta and BMP signaling. Understanding this complex is important for cancer, fibrosis, and developmental biology research. EDITGENE provides comprehensive CRISPR services, including knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics, to support mechanistic and translational studies of homomeric SMAD protein complexes.
References
- 1. Ross S et al.. 2008. How the Smads regulate transcription.. Int J Biochem Cell Biol 40(3):383-408 PMID: 18061509
- 2. Marom B et al.. 2011. Formation of stable homomeric and transient heteromeric bone morphogenetic protein (BMP) receptor complexes regulates Smad protein signaling.. J Biol Chem 286(22):19287-96 PMID: 21471205
- 3. Lv Y et al.. 2022. Regulatory roles of an atypical ubiquitin ligase UBE2O in orphans of multiprotein complexes for degradation.. Turk J Biol 46(2):186-194 PMID: 37533513
- 4. Maurice D et al.. 2001. Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability.. J Biol Chem 276(46):43175-81 PMID: 11553622
- 5. Vindevoghel L et al.. 1998. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta.. Proc Natl Acad Sci U S A 95(25):14769-74 PMID: 9843964
- 6. Tazat K et al.. 2015. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.. Mol Biol Cell 26(19):3535-45 PMID: 26269580
- 7. Nohe A et al.. 2002. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.. J Biol Chem 277(7):5330-8 PMID: 11714695
- 8. Saka Y et al.. 2007. Nuclear accumulation of Smad complexes occurs only after the midblastula transition in Xenopus.. Development 134(23):4209-18 PMID: 17959720
